AHA Scientific Sessions 2026 Abstract

Vessel-cell enzyme helped drive artery plaque buildup in mice

Mice with high cholesterol developed less artery plaque when researchers deleted an enzyme from blood-vessel lining cells in experiments on disturbed blood flow.

Paper by Venkata Subrahmanya Kumar Samanthapudi, Kun Yuan Chu, Gilbert F. Mejia, +10 more authorsJunichi Abe · The University of Texas MD Anderson Cancer Center
An opened artery with heavy plaque and a constricting loop sits beside a smaller artery with little plaque and a laboratory mouse.

Our read

Mechanisms
Studied:
Experiments in hypercholesterolemic mice
What changed:
Deleting endothelial protein kinase C zeta reduced artery plaque buildup in mice
The catch:
The abstract does not give mouse group sizes or the plaque reduction size
In the record:
One of 4 papers on disturbed flow on record: 1 with results in people, 1 in animals.
Why it’s aging research:
It studies something that builds up in the body with age.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Mice with high cholesterol underwent surgery to partly tie off a carotid artery in an animal experiment on disturbed blood flow. The researchers also examined endothelial cells—the cells lining blood vessels—in the lab. In mice, deleting protein kinase C zeta, an enzyme, specifically in endothelial cells reduced artery plaque buildup.

The authors concluded that the enzyme added a chemical tag to TERF2IP, a protein involved in protecting chromosome ends. This tagging promoted the breakdown of signaling proteins called LATS1/2 and promoted senescence, a state in which cells stop dividing. The authors concluded that this pathway linked disturbed flow to vessel-lining cell dysfunction and atherosclerosis, the buildup of fatty plaques in arteries.

Why it matters

Senescence in vessel-lining cells connects this work to vascular aging. The authors suggested that targeting the pathway may offer a strategy for vascular disease linked to disturbed blood flow.

Caveats

The experiments involved cells grown in the lab and mice with high cholesterol, not people. The conference abstract does not give mouse group sizes or the size of the plaque reduction.

Comments

Be the first to comment.